Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT04975399 · TERMINATED
Trial details
- NCT number
- NCT04975399
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2024-06-18
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.